Literature DB >> 24292568

Role of cytokines as a double-edged sword in sepsis.

Hina Chaudhry1, Juhua Zhou, Yin Zhong, Mir Mustafa Ali, Franklin McGuire, Prakash S Nagarkatti, Mitzi Nagarkatti.   

Abstract

BACKGROUND: Sepsis is a deadly immunological disorder and its pathophysiology is still poorly understood. We aimed to determine if specific pro-inflammatory and anti-inflammatory cytokines can be used as diagnostic and therapeutic targets for sepsis.
MATERIALS AND METHODS: Recent publications in the MEDLINE database were searched for articles regarding the clinical significance of inflammatory cytokines in sepsis.
RESULTS: In response to pathogen infection, pro-inflammatory cytokines [interleukin-6 (IL-6), IL-8, IL-18 and tumor necrosis factor-α (TNF-α)] and anti-inflammatory cytokine (IL-10) increased in patients with sepsis. Importantly, a decrease in IL-6 was associated with a better prognosis and overproduction of IL-10 was found to be the main predictor of severity and fatal outcome.
CONCLUSION: Both pro-inflammatory and anti-inflammatory cytokines constitute a double-edged sword in sepsis; on one hand they are critical to eliminate the infection while on the other, excessive production can cause tissue and organ damage. Increase in cytokines such as IL-6, Il-8, IL-10, IL-18 and TNF-α may have implications in diagnosis and treatment of sepsis.

Entities:  

Keywords:  Sepsis; anti-inflammatory; biomarker; cytokine; pro-inflammatory; review; signaling pathway

Mesh:

Substances:

Year:  2013        PMID: 24292568      PMCID: PMC4378830     

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  150 in total

Review 1.  Induction of interleukin-1 and interleukin-1 receptor antagonist.

Authors:  C A Dinarello
Journal:  Semin Oncol       Date:  1997-06       Impact factor: 4.929

2.  A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist.

Authors:  H Schreuder; C Tardif; S Trump-Kallmeyer; A Soffientini; E Sarubbi; A Akeson; T Bowlin; S Yanofsky; R W Barrett
Journal:  Nature       Date:  1997-03-13       Impact factor: 49.962

3.  Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis.

Authors:  F Arnalich; D López-Maderuelo; R Codoceo; J Lopez; L M Solis-Garrido; C Capiscol; C Fernandez-Capitán; R Madero; C Montiel
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: the Caerphilly Study.

Authors:  Christopher C Patterson; Anne E Smith; John W G Yarnell; Ann Rumley; Yoav Ben-Shlomo; Gordon D O Lowe
Journal:  Atherosclerosis       Date:  2009-09-27       Impact factor: 5.162

5.  A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis.

Authors:  Nathan I Shapiro; Stephen Trzeciak; Judd E Hollander; Robert Birkhahn; Ronny Otero; Tiffany M Osborn; Eugene Moretti; H Bryant Nguyen; Kyle J Gunnerson; David Milzman; David F Gaieski; Munish Goyal; Charles B Cairns; Long Ngo; Emanuel P Rivers
Journal:  Crit Care Med       Date:  2009-01       Impact factor: 7.598

6.  Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats.

Authors:  H R Alexander; G M Doherty; D J Venzon; M J Merino; D L Fraker; J A Norton
Journal:  Surgery       Date:  1992-08       Impact factor: 3.982

7.  Novel cyclohexene derivatives as anti-sepsis agents: synthetic studies and inhibition of NO and cytokine production.

Authors:  Masami Yamada; Takashi Ichikawa; Masayuki Ii; Katsumi Itoh; Norikazu Tamura; Tomoyuki Kitazaki
Journal:  Bioorg Med Chem       Date:  2008-01-24       Impact factor: 3.641

8.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

Review 9.  GM-CSF in inflammation and autoimmunity.

Authors:  John A Hamilton
Journal:  Trends Immunol       Date:  2002-08       Impact factor: 16.687

10.  Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit.

Authors:  Canan BalcI; Hülya Sungurtekin; Ercan Gürses; Ugur Sungurtekin; Bünyamin Kaptanoglu
Journal:  Crit Care       Date:  2002-10-30       Impact factor: 9.097

View more
  160 in total

1.  Central GABAA receptors are involved in inflammatory and cardiovascular consequences of endotoxemia in conscious rats.

Authors:  Marwa Y Sallam; Sahar M El-Gowilly; Abdel-Galil A Abdel-Galil; Mahmoud M El-Mas
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-21       Impact factor: 3.000

Review 2.  Immunometabolism: Another Road to Sepsis and Its Therapeutic Targeting.

Authors:  Vijay Kumar
Journal:  Inflammation       Date:  2019-06       Impact factor: 4.092

3.  The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load.

Authors:  Kjetil H Egge; Andreas Barratt-Due; Stig Nymo; Julie K Lindstad; Anne Pharo; Corinna Lau; Terje Espevik; Ebbe B Thorgersen; Tom E Mollnes
Journal:  Clin Exp Immunol       Date:  2015-07-19       Impact factor: 4.330

Review 4.  The role of bone cells in immune regulation during the course of infection.

Authors:  Asuka Terashima; Hiroshi Takayanagi
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

Review 5.  Redox stress unbalances the inflammatory cytokine network: role in autoinflammatory patients and healthy subjects.

Authors:  Rosa Lavieri; Anna Rubartelli; Sonia Carta
Journal:  J Leukoc Biol       Date:  2015-07-21       Impact factor: 4.962

6.  One-hit wonder: Late after burn injury, granulocytes can clear one bacterial infection but cannot control a subsequent infection.

Authors:  Laurel B Kartchner; Cindy J Gode; Julia L M Dunn; Lindsey I Glenn; Danté N Duncan; Matthew C Wolfgang; Bruce A Cairns; Robert Maile
Journal:  Burns       Date:  2019-03-02       Impact factor: 2.744

7.  Association of sepsis with risk for osteoporosis: a population-based cohort study.

Authors:  Y-F Lee; P-Y Leong; H-K Tsou; Y-H Wang; J C-C Wei
Journal:  Osteoporos Int       Date:  2020-08-22       Impact factor: 4.507

Review 8.  Gasdermin D (GSDMD) as a new target for the treatment of infection.

Authors:  Ankit Pandeya; Lan Li; Zhenyu Li; Yinan Wei
Journal:  Medchemcomm       Date:  2019-04-04       Impact factor: 3.597

9.  IL-1β suppression of VE-cadherin transcription underlies sepsis-induced inflammatory lung injury.

Authors:  Shiqin Xiong; Zhigang Hong; Long Shuang Huang; Yoshikazu Tsukasaki; Saroj Nepal; Anke Di; Ming Zhong; Wei Wu; Zhiming Ye; Xiaopei Gao; Gadiparthi N Rao; Dolly Mehta; Jalees Rehman; Asrar B Malik
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

10.  Effects of simvastatin on the function of splenic CD4+ and CD8+ T cells in sepsis mice.

Authors:  Bingbing Kong; Xiaofeng Wang; Wenping Yang; Xin Zhao; Rong Zhang; Yu Wang
Journal:  Immunol Res       Date:  2018-06       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.